ARS Pharmaceuticals, Inc. SPRY Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssets.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s other non-current assets?
- ARS Pharmaceuticals, Inc. (SPRY) reported other non-current assets of $2.65M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s other non-current assets changed year-over-year?
- ARS Pharmaceuticals, Inc.'s other non-current assets decreased by 15.3% year-over-year, from $3.13M to $2.65M.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s other non-current assets?
- Over 4 years (2021 to 2025), ARS Pharmaceuticals, Inc.'s other non-current assets has grown at a 231.8% compound annual growth rate (CAGR), from $23K to $2.79M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.